Patient with rare disease treated at Kozhikode hospital

She was diagnosed with primary plasma cell leukemia

Published - January 11, 2022 02:19 am IST - KOZHIKODE

A 47-year-old person suffering from primary plasma cell leukemia, a rare and aggressive form of blood cancer, was cured through treatment at Meitra Hospital, Kozhikode, recently.

According to a release from the hospital, the patient was initially diagnosed for low platelet count and overall fatigue at another hospital. She was confirmed to have been suffering from primary plasma cell leukemia after undergoing diagnostic tests and was referred to the Myeloma Clinic under Centre of Excellence for Blood Diseases, Bone Marrow Transplant and Cancer Immunotherapy at Meitra Hospital.

Primary plasma cell leukaemia, known to be a sub-type of multiple myeloma, occurs when the cancerous plasma cells within the bone marrow spread to the blood. It is a rare type and is aggressive than multiple myeloma. It occurs when the onset of developing cancer is in its original form instead of spreading to the blood from any other type of cancer. The patient was initially treated with anti-plasma cell therapy, followed by bone marrow transplant and was discharged after recovering from the treatment, the release said.

Ragesh Radhakrishnan Nair, Director, Hemato-Oncology and Bone Marrow Transplant, Meitra Hospital, said, “Globally, we see only about four cases among one crore patients annually. That means, in India, the incidence might be around 400 cases in a year, mostly found in female patients. Owing to its aggressive nature, administering the right treatment at the right time is crucial.”

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.